Current status: Answered by Jenni Minto on 19 April 2024
To ask the Scottish Government, further to the answer to question S6F-02948 by Humza Yousaf on 21 March 2024, whether it will confirm if it has any plans to restrict the use of puberty suppressing hormones for children.
Decisions on clinical pathways are not for the Scottish Government. These decisions are for clinicians, based on the best evidence available, through the appropriate clinical governance structures.
On 18 April, in a joint statement, NHS Greater Glasgow and Clyde and NHS Lothian confirmed that both Boards have paused any new prescription of puberty-supressing hormones and cross-sex hormones for young people as a treatment option for gender dysphoria.
The small number of patients directly impacted by this change, and their families, were notified in advance of this statement. It is right that they were the first to hear about it, sensitively and from the services caring for them, before a public statement was made.